About: Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $31.55 (-6.66%)
NBTX NASDAQ Nanobiotix
Nanobiotix share price
NBTX price activity
Last Price
$31.370
Change (24hr)
-2.43 USD (7.19%)
Volume
235.67K
Volume (4w avg)
-
Open
$32.50
Day Range
$31.10 - $33.44
Previous Close
$33.80
Last Trade
30 Oct, 8:00 pm GMT+0
Delayed
30 Oct, 8:00 pm GMT+0
NBTX price performance
Delayed
30 Oct, 8:00 pm GMT+0
NBTX Market Signals